17/05/2023 ESTEVE REPORTS SIGNIFICANT GROWTH IN 2022 AND CONTINUES TO ADVANCE TOWARDS ITS VISION OF BECOMING AN INTERNATIONAL SPECIALTY PHARMA COMPANY Leggi
07/03/2023 ESTEVE BRINGS TO MARKET THE FIRST INHALED RESCUE TREATMENT DESIGNED TO CONTROL OFF EPISODES IN PARKINSON’S DISEASE¹ Leggi
Contatto stampa Per ulteriori informazioni, contattare: Irene Simón Head of Global External Comms & ESG + 34 93 446 60 00isimon@esteve.com